- Home
- GHRS vs MVST Comparison
GHRS vs MVST Comparison
Compare GHRS & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- MVST
- Stock Information
- Founded
- GHRS 2018
- MVST 2006
- Country
- GHRS Ireland
- MVST United States
- Employees
- GHRS N/A
- MVST N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- MVST Industrial Machinery/Components
- Sector
- GHRS Health Care
- MVST Miscellaneous
- Exchange
- GHRS Nasdaq
- MVST Nasdaq
- Market Cap
- GHRS 892.0M
- MVST 848.0M
- IPO Year
- GHRS 2021
- MVST N/A
- Fundamental
- Price
- GHRS $14.38
- MVST $3.42
- Analyst Decision
- GHRS Strong Buy
- MVST Strong Buy
- Analyst Count
- GHRS 9
- MVST 1
- Target Price
- GHRS $30.11
- MVST $6.00
- AVG Volume (30 Days)
- GHRS 407.8K
- MVST 6.5M
- Earning Date
- GHRS 11-06-2025
- MVST 11-10-2025
- Dividend Yield
- GHRS N/A
- MVST N/A
- EPS Growth
- GHRS N/A
- MVST N/A
- EPS
- GHRS N/A
- MVST N/A
- Revenue
- GHRS N/A
- MVST $444,504,000.00
- Revenue This Year
- GHRS N/A
- MVST $24.14
- Revenue Next Year
- GHRS N/A
- MVST $28.49
- P/E Ratio
- GHRS N/A
- MVST N/A
- Revenue Growth
- GHRS N/A
- MVST 19.82
- 52 Week Low
- GHRS $6.72
- MVST $0.63
- 52 Week High
- GHRS $20.50
- MVST $7.12
- Technical
- Relative Strength Index (RSI)
- GHRS 55.96
- MVST 30.64
- Support Level
- GHRS $13.71
- MVST $3.19
- Resistance Level
- GHRS $15.01
- MVST $3.79
- Average True Range (ATR)
- GHRS 0.98
- MVST 0.36
- MACD
- GHRS 0.04
- MVST -0.16
- Stochastic Oscillator
- GHRS 74.17
- MVST 10.56
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.